Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares. AI is about to change ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies, has been garnering significant attention from analysts and ...

Meeting to be held in Boston on April 9 and in New York on April 10 hosted by Piper Sandler.Stay Ahead of the Market: Discover outperforming ...

Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies, has been garnering significant attention from analysts ...

Schroder Investment Management Group lessened its position in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 9.6% in the fourth quarter, according to its most recent disclosure with the SEC.